Search Results - "MORABITO, F"

European Myeloma Network guidelines for the management of multiple myeloma-related complications by Terpos, Evangelos, Kleber, Martina, Engelhardt, Monika, Zweegman, Sonja, Gay, Francesca, Kastritis, Efstathios, van de Donk, Niels W C J, Bruno, Benedetto, Sezer, Orhan, Broijl, Annemiek, Bringhen, Sara, Beksac, Meral, Larocca, Alessandra, Hajek, Roman, Musto, Pellegrino, Johnsen, Hans Erik, Morabito, Fortunato, Ludwig, Heinz, Cavo, Michele, Einsele, Hermann, Sonneveld, Pieter, Dimopoulos, Meletios A, Palumbo, Antonio

“…The European Myeloma Network provides recommendations for the management of the most common complications of multiple myeloma. Whole body low-dose computed…”
Get full text

An Effective Approach to the Synthesis of Phase-Only Reconfigurable Linear Arrays by Morabito, A. F., Massa, A., Rocca, P., Isernia, T.

“…We present an effective approach to the optimal mask-constrained power pattern synthesis of uniformly spaced array antennas able to dynamically reconfigure…”
Get full text

Reconstructing the membrane detection of a 1D electrostatic-driven MEMS device by the shooting method: convergence analysis and ghost solutions identification by Angiulli, Giovanni, Jannelli, Alessandra, Morabito, F. Carlo, Versaci, Mario

“…In this paper, in the domain of 1 D -membrane micro-electro-mechanical systems in which the electrostatic field is expressed in terms of geometric curvature of…”
Get full text

Demonstration for cold atmospheric pressure plasma jet operation and antibacterial action in microgravity by Rouillard, A., Escot Bocanegra, P., Stancampiano, A., Dozias, S., Lemaire, J., Pouvesle, J. M., Robert, E., Brulé-Morabito, F., Demasure, M., Rouquette, S.

“…Cold atmospheric pressure plasma (ionized gas) is an innovative medical tool for the treatment of infected wounds thanks to its potential to inactivate…”
Get full text

A Machine-learning and Compressive-sensing Inspired Approach to the Optimal Array Pattern Synthesis by Morabito, A. F., Ieracitano, C., Morabito, F. C.

“…We propose a new approach to the power-pattern optimal synthesis of 1-D array antennas. The technique pursues the minimization of the number of active elements…”
Get full text

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy by Martino, M, Tripepi, G, Messina, G, Vincelli, I D, Console, G, Recchia, A G, Gentile, M, Molica, S, Morabito, F

“…This phase II trial evaluates, for the first time, the safety and efficacy of bendamustine plus high-dose melphalan (HDM) as a conditioning regimen before the…”
Get full text

IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia by Reda, G., Cassin, R., Gentile, M., Mauro, F. R., Giannarelli, D., Fattizzo, B., Barbieri, M., Silvestris, I., Fabris, S., Morabito, F., Neri, A., Barcellini, W., Cortelezzi, A.

Get full text

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 by Amodio, N, Di Martino, M T, Foresta, U, Leone, E, Lionetti, M, Leotta, M, Gullà, A M, Pitari, M R, Conforti, F, Rossi, M, Agosti, V, Fulciniti, M, Misso, G, Morabito, F, Ferrarini, M, Neri, A, Caraglia, M, Munshi, N C, Anderson, K C, Tagliaferri, P, Tassone, P

“…MicroRNAs (miRNAs) with tumor-suppressor potential might have therapeutic applications in multiple myeloma (MM) through the modulation of still undiscovered…”
Get full text

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy by Cutrona, G, Matis, S, Colombo, M, Massucco, C, Baio, G, Valdora, F, Emionite, L, Fabris, S, Recchia, A G, Gentile, M, Neumaier, C E, Reverberi, D, Massara, R, Boccardo, S, Basso, L, Salvi, S, Rosa, F, Cilli, M, Zupo, S, Truini, M, Tassone, P, Calabrese, M, Negrini, M, Neri, A, Morabito, F, Fais, F, Ferrarini, M

“…Chronic lymphocytic leukemia (CLL) clones are characterized by loss of a critical region in 13q14.3, (del(13)(q14)) involving the microRNA (miRNA) cluster…”
Get full text

Optimal Synthesis of Sum and Difference Patterns With Arbitrary Sidelobes Subject to Common Excitations Constraints by Morabito, A F, Rocca, P

“…An innovative and computationally effective approach to the synthesis of optimal sum and difference patterns via uniformly spaced arrays with a number of…”
Get full text

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma by Palumbo, A., Gay, F., Bringhen, S., Falcone, A., Pescosta, N., Callea, V., Caravita, T., Morabito, F., Magarotto, V., Ruggeri, M., Avonto, I., Musto, P., Cascavilla, N., Bruno, B., Boccadoro, M.

“…Bortezomib has shown significant activity in myeloma. In this multicenter trial, we assessed for the first time the combination of bortezomib, doxorubicin and…”
Get full text

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease by Mauro, F R, Chauvie, S, Paoloni, F, Biggi, A, Cimino, G, Rago, A, Gentile, M, Morabito, F, Coscia, M, Bellò, M, Sacchetti, G M, Rossi, D, Laurenti, L, Autore, F, Campanelli, M, Trastulli, F, Nicolai, E, Riminucci, M, Gaidano, G, Guarini, A, Gallamini, A, Foà, R

“…In order to evaluate the predictive value of positron emission tomography–computed tomography (PET/CT) in discriminating the presence of a Richter’s syndrome…”
Get full text

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma by Larocca, A, Bringhen, S, Petrucci, M T, Oliva, S, Falcone, A P, Caravita, T, Villani, O, Benevolo, G, Liberati, A M, Morabito, F, Montefusco, V, Passera, R, De Rosa, L, Omedé, P, Vincelli, I D, Spada, S, Carella, A M, Ponticelli, E, Derudas, D, Genuardi, M, Guglielmelli, T, Nozzoli, C, Aghemo, E, De Paoli, L, Conticello, C, Musolino, C, Offidani, M, Boccadoro, M, Sonneveld, P, Palumbo, A

“…This phase 2 trial evaluated three low-dose intensity subcutaneous bortezomib-based treatments in patients ⩾75 years with newly diagnosed multiple myeloma…”
Get full text

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial by Cortelezzi, A, Sciumè, M, Liberati, A M, Vincenti, D, Cuneo, A, Reda, G, Laurenti, L, Zaja, F, Marasca, R, Chiarenza, A, Gritti, G, Orsucci, L, Storti, S, Angelucci, E, Cascavilla, N, Gobbi, M, Mauro, F R, Morabito, F, Fabris, S, Piciocchi, A, Vignetti, M, Neri, A, Rossi, D, Giannarelli, D, Guarini, A, Foà, R

“…We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) study (CLL0809) to assess the…”
Get full text

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients by Gentile, M, Shanafelt, T D, Cutrona, G, Molica, S, Tripepi, G, Alvarez, I, Mauro, F R, Di Renzo, N, Di Raimondo, F, Vincelli, I, Todoerti, K, Matis, S, Musolino, C, Fabris, S, Vigna, E, Levato, L, Zupo, S, Angrilli, F, Consoli, U, Festini, G, Longo, G, Cortelezzi, A, Arcari, A, Federico, M, Mannina, D, Recchia, A G, Neri, A, Kay, N E, Ferrarini, M, Morabito, F

Get full text

A Finite-Difference Approach for Plasma Microwave Imaging Profilometry by Di Donato, Loreto, Mascali, David, Morabito, Andrea F., Sorbello, Gino

“…Plasma diagnostics is a topic of great interest in the physics and engineering community because the monitoring of plasma parameters plays a fundamental role…”
Get full text

N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity by Bruno, S, Ghiotto, F, Tenca, C, Mazzarello, A N, Bono, M, Luzzi, P, Casciaro, S, Recchia, A, DeCensi, A, Morabito, F, Fais, F

“…The in vitro effects of the synthetic retinoid N -(4-hydroxyphenyl)retinamide (4HPR, fenretinide) on primary B-cell chronic lymphocytic leukemia (CLL) cells…”
Get full text

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome by Ronchetti, D, Manzoni, M, Agnelli, L, Vinci, C, Fabris, S, Cutrona, G, Matis, S, Colombo, M, Galletti, S, Taiana, E, Recchia, A G, Bossio, S, Gentile, M, Musolino, C, Di Raimondo, F, Grilli, A, Bicciato, S, Cortelezzi, A, Tassone, P, Morabito, F, Ferrarini, M, Neri, A

“…Long non-coding RNAs (lncRNAs) represent a novel class of functional RNA molecules with an important emerging role in cancer. To elucidate their potential…”
Get full text

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: Extension and analysis of a previously reported cohort of patients by Miglietta, L, Morabito, F, Provinciali, N, Canobbio, L, Meszaros, P, Naso, C, Murialdo, R, Boitano, M, Salvi, S, Ferrarini, M

“…Abstract Background Ki-67 expression has gained attention as a breast cancer prognostic factor, however its significance in the remaining malignant cells after…”
Get full text

Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors by INVITTI, C, MAFFEIS, C, GILARDINI, L, PONTIGGIA, B, MAZZILLI, G, GIROLA, A, SARTORIO, A, MORABITO, F, VIBERTI, G. C

“…Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if…”
Get full text